These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26228640)

  • 1. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains.
    Drago L; De Vecchi E; Bortolin M; Toscano M; Mattina R; Romanò CL
    Future Microbiol; 2015; 10(8):1293-9. PubMed ID: 26228640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    Bortolin M; De Vecchi E; Romanò CL; Toscano M; Mattina R; Drago L
    J Antimicrob Chemother; 2016 Jan; 71(1):123-7. PubMed ID: 26462989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
    BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
    Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A
    Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibiofilm activity of bioactive glass S53P4.
    Drago L; Vassena C; Fenu S; De Vecchi E; Signori V; De Francesco R; Romanò CL
    Future Microbiol; 2014; 9(5):593-601. PubMed ID: 24957087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
    Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
    Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on antibacterial effect of 45S5 Bioglass.
    Hu S; Chang J; Liu M; Ning C
    J Mater Sci Mater Med; 2009 Jan; 20(1):281-6. PubMed ID: 18763024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5.
    Zhou P; Garcia BL; Kotsakis GA
    BMC Microbiol; 2022 Sep; 22(1):212. PubMed ID: 36050654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro biological and anti-bacterial study on a sol-gel derived silver-incorporated bioglass system.
    Balamurugan A; Balossier G; Laurent-Maquin D; Pina S; Rebelo AH; Faure J; Ferreira JM
    Dent Mater; 2008 Oct; 24(10):1343-51. PubMed ID: 18405962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of pH and fluid dynamics on the antibacterial efficacy of 45S5 Bioglass.
    Begum S; Johnson WE; Worthington T; Martin RA
    Biomed Mater; 2016 Feb; 11(1):015006. PubMed ID: 26836582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure.
    Müller N; Kollert M; Trampuz A; Gonzalez Moreno M
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of S53P4 bone substitute on staphylococcal adhesion and biofilm formation on other implant materials in normal and hypoxic conditions.
    Pérez-Tanoira R; García-Pedrazuela M; Hyyrynen T; Soininen A; Aarnisalo A; Nieminen MT; Tiainen VM; Konttinen YT; Kinnari TJ
    J Mater Sci Mater Med; 2015 Sep; 26(9):239. PubMed ID: 26403279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE; de Andrade E Silva FB; Leonhardt MC; de Carvalho VC; de Oliveira PRD; Lima ALLM; Roberto Dos Reis P; Silva JDS
    Injury; 2021 Jul; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG-S53P4 as an additive to bone allografts: A laboratory study using an uniaxial compression test.
    Putzer D; Fuchs J; Coraça-Huber D; Christoph A; Liebensteiner M; Nogler M
    J Orthop Res; 2015 Dec; 33(12):1875-9. PubMed ID: 26016590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.